ONWARDS 11 Study

Written By Patrick Smith

Type 1 Diabetes (T1D)

This study is evaluating and investigational once-weekly basal (long-acting) insulin (insulin ICODEC) in combination with a rapid-acting (mealtime) insulin in people with T1D who are not achieving glucose targets using a multiple daily injection (MDI) insulin regimen.

This study is investigating a once-weekly long-acting insulin (insulin icodec) compared to daily insulin glargine, both used in combination with a rapid-acting (mealtime) insulin (insulin aspart), in adults living with type 1 diabetes being treated with multiple daily insulin (MDI) injections.

If you are considering participating in this clinical research study, please complete the form and someone from our team will reach out to you.

Patrick Smith
Previous

CAPTAIN T2D Study
Next

Weight Management Studies Coming Soon